Trial · NCT02008565
Results by group112
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 112
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline St. Mark's (Vaizey) Score | Loperamide - Exercise Plus Biofeedback | 12 Week St. Mark's Score | -5.5 | 95% Confidence Interval -7.2 to -3.9 | units on a scale |
| Change From Baseline St. Mark's (Vaizey) Score | Placebo - Exercise Plus Biofeedback | 12 Week St. Mark's Score | -4.4 | 95% Confidence Interval -6.0 to -2.8 | units on a scale |
| Change From Baseline St. Mark's (Vaizey) Score | Loperamide - Education Only | 12 Week St. Mark's Score | -4.5 | 95% Confidence Interval -6.1 to -2.9 | units on a scale |
| Change From Baseline St. Mark's (Vaizey) Score | Placebo - Education Only | 12 Week St. Mark's Score | -3.4 | 95% Confidence Interval -6.0 to -0.8 | units on a scale |
| Change From Baseline St. Mark's (Vaizey) Score | Loperamide - Exercise Plus Biofeedback | 24 Week St. Mark's Score | -9.7 | 95% Confidence Interval -11.9 to -7.5 | units on a scale |
| Change From Baseline St. Mark's (Vaizey) Score | Placebo - Exercise Plus Biofeedback | 24 Week St. Mark's Score | -5.9 | 95% Confidence Interval -8.1 to -3.7 | units on a scale |
| Change From Baseline St. Mark's (Vaizey) Score | Loperamide - Education Only | 24 Week St. Mark's Score | -6.2 | 95% Confidence Interval -8.1 to -4.2 | units on a scale |
| Change From Baseline St. Mark's (Vaizey) Score | Placebo - Education Only | 24 Week St. Mark's Score | -4.5 | 95% Confidence Interval -7.1 to -1.9 | units on a scale |
| Change in Quality of Life on Colorectal-Anal Distress Inventory (CRADI) | Loperamide - Exercise Plus Biofeedback | 12 Week CRADI Score | -16.3 | 95% Confidence Interval -22.4 to -10.1 | units on a scale |
| Change in Quality of Life on Colorectal-Anal Distress Inventory (CRADI) | Placebo - Exercise Plus Biofeedback | 12 Week CRADI Score | -13.1 | 95% Confidence Interval -19.2 to -7.1 | units on a scale |
| Change in Quality of Life on Colorectal-Anal Distress Inventory (CRADI) | Loperamide - Education Only | 12 Week CRADI Score | -16.9 | 95% Confidence Interval -22.8 to -11.1 | units on a scale |
| Change in Quality of Life on Colorectal-Anal Distress Inventory (CRADI) | Placebo - Education Only | 12 Week CRADI Score | -4.6 | 95% Confidence Interval -14.2 to 5.1 | units on a scale |
| Change in Quality of Life on Colorectal-Anal Distress Inventory (CRADI) | Loperamide - Exercise Plus Biofeedback | 24 Week CRADI Score | -21.5 | 95% Confidence Interval -27.6 to -15.4 | units on a scale |
| Change in Quality of Life on Colorectal-Anal Distress Inventory (CRADI) | Placebo - Exercise Plus Biofeedback | 24 Week CRADI Score | -15.7 | 95% Confidence Interval -21.7 to -9.6 | units on a scale |
| Change in Quality of Life on Colorectal-Anal Distress Inventory (CRADI) | Loperamide - Education Only | 24 Week CRADI Score | -21.7 | 95% Confidence Interval -27.6 to -15.9 | units on a scale |
| Change in Quality of Life on Colorectal-Anal Distress Inventory (CRADI) | Placebo - Education Only | 24 Week CRADI Score | -15.7 | 95% Confidence Interval -25.4 to -5.9 | units on a scale |
| Change in Colorectal-Anal Subscale of the Pelvic Floor Impact Questionnaire Short Form (CRAIQ) Score | Loperamide - Exercise Plus Biofeedback | 12 Weeks | -12.5 | 95% Confidence Interval -18.5 to -6.4 | units on a scale |
| Change in Colorectal-Anal Subscale of the Pelvic Floor Impact Questionnaire Short Form (CRAIQ) Score | Placebo - Exercise Plus Biofeedback | 12 Weeks | -10.8 | 95% Confidence Interval -16.8 to -4.9 | units on a scale |
| Change in Colorectal-Anal Subscale of the Pelvic Floor Impact Questionnaire Short Form (CRAIQ) Score | Loperamide - Education Only | 12 Weeks | -15.8 | 95% Confidence Interval -21.6 to -9.9 | units on a scale |
| Change in Colorectal-Anal Subscale of the Pelvic Floor Impact Questionnaire Short Form (CRAIQ) Score | Placebo - Education Only | 12 Weeks | -12.3 | 95% Confidence Interval -21.9 to -2.8 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02008565/results